A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dressing

NCT06625385 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-02-13

No results posted yet for this study

Summary

The purpose of this clinical study is to obtain post-market safety and efficacy data when the V.A.C.® Peel and Place dressing is used in conjunction with 3M™ V.A.C.® Therapy.

Conditions

  • Wound

Interventions

DEVICE

3M™ V.A.C.® Peel and Place Dressing

Application of 3M™ V.A.C.® Peel and Place Dressing used in conjunction with 3M™ V.A.C.® Therapy

Sponsors & Collaborators

  • Solventum US LLC

    lead INDUSTRY

Principal Investigators

  • Stephanie Karwedsky · Solventum

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-20
Primary Completion
2026-12-31
Completion
2027-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06625385 on ClinicalTrials.gov